Company
LB Pharmaceuticals
Developing Novel Therapies for the Treatment of Schizophrenia, Bipolar Depression, and Other Neuropsychiatric Diseases
Also known as LB Pharmaceuticals Inc
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- LB Pharmaceuticals Inc
Claim, correct or request removal
Record updated 28 September 2026
About
LB Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases.
Funding snapshot
- Total raised
- $141MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $111M2023-08-29
Funding rounds
- Round, 2023
- $111M2023-08-29, SEC form D sold, 6 investors
- Round, 2022
- $16.6M2022-10-21, SEC form D sold, 71 investors
- Round, 2022
- $903K2022-05-03, SEC form D sold, 35 investors
- Round, 2020
- $4.6M2020-08-18, SEC form D sold, 35 investors
- Round, 2018
- $6.3M2018-11-21, SEC form D sold, 74 investors
- Round, 2018
- $330K2018-05-03, SEC form D sold, 11 investors
- Round, 2017
- $443K2017-12-20, SEC form D sold, 7 investors
- Round, 2017
- $462K2017-04-05, SEC form D sold, 8 investors
- Round, 2016
- $969K2016-11-25, SEC form D sold, 13 investors
Products
- Other
- LB-102
Loading relationship preview